Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fateh

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Cancer|August 1, 1993
CYFRA 21-1. A new marker in lung cancerP Stieber, U Hasholzner, H Bodenmüller, et al.
Acta Endocrinologica|August 1, 1979
Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serumP C Scriba, M Bauer, D Emmert, et al.
Scandinavian Journal of Haematology|October 1, 1983
Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognitionR Bartl, B Frisch, G Mahl, et al.
Neurology|November 1, 1991
Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671R Voltz, R Hohlfeld, A Fateh-Moghadam, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|April 1, 1989
Measurement of proteins with the Behring Nephelometer. A multicentre evaluationP C Fink, M Römer, R Haeckel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1980
Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgGK V Toyka, B Löwenadler, K Heininger, et al.
Klinische Wochenschrift|September 17, 1979
[The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)]K V Toyka, T Becker, A Fateh-Moghadam, et al.
British Journal of Cancer|April 16, 2002
Serum CEA and CA 15-3 as prognostic factors in primary breast cancerF G Ebeling, P Stieber, M Untch, et al.
Scientific Reports|February 15, 2018
Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa CellsMuhammad U Farooq, Valentyn Novosad, Elena A Rozhkova, et al.
Scientific Reports|July 5, 2022
Retraction Note: Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa cellsMuhammad U Farooq, Valentyn Novosad, Elena A Rozhkova, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Cancer|August 1, 1993
CYFRA 21-1. A new marker in lung cancerP Stieber, U Hasholzner, H Bodenmüller, et al.
Acta Endocrinologica|August 1, 1979
Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serumP C Scriba, M Bauer, D Emmert, et al.
Scandinavian Journal of Haematology|October 1, 1983
Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognitionR Bartl, B Frisch, G Mahl, et al.
Neurology|November 1, 1991
Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671R Voltz, R Hohlfeld, A Fateh-Moghadam, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|April 1, 1989
Measurement of proteins with the Behring Nephelometer. A multicentre evaluationP C Fink, M Römer, R Haeckel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1980
Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgGK V Toyka, B Löwenadler, K Heininger, et al.
Klinische Wochenschrift|September 17, 1979
[The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)]K V Toyka, T Becker, A Fateh-Moghadam, et al.
British Journal of Cancer|April 16, 2002
Serum CEA and CA 15-3 as prognostic factors in primary breast cancerF G Ebeling, P Stieber, M Untch, et al.
Scientific Reports|February 15, 2018
Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa CellsMuhammad U Farooq, Valentyn Novosad, Elena A Rozhkova, et al.
Scientific Reports|July 5, 2022
Retraction Note: Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa cellsMuhammad U Farooq, Valentyn Novosad, Elena A Rozhkova, et al.
Pageof 15